AAS
GALT icon

Ameritas Advisory Services’s Galectin Therapeutics GALT Stock Holding History

Ameritas Advisory Services’s Portfolio GALT Stock Details GALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-44,232
Closed -$64.6K – 816
2023
Q2 		$64.6K Sell
44,232
-1,070
-2% -$1.81K 0.01% 539
2023
Q1 		$94.9K Hold
45,302
– – ﹤0.01% 1023
2022
Q4 		$51.2K Hold
45,302
– – ﹤0.01% 863
2022
Q3 		$74K Hold
45,302
– – ﹤0.01% 742
2022
Q2 		$59K Buy
45,302
+1,070
+2% +$1.54K ﹤0.01% 784
2022
Q1 		$71K Hold
44,232
– – ﹤0.01% 818
2021
Q4 		$92K Buy
+44,232
New +$126K ﹤0.01% 798

Other funds holding GALT

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GWM
Geneos Wealth Management Englewood, Colorado $4.31B AUM 18.36% 1-Year Est. Return
AWS
Atria Wealth Solutions New York $4.42B AUM 16.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WANY
Wealthspire Advisors (New York) New York $12.7B AUM 17.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return